BioCentury
ARTICLE | Company News

AnorMed, British Biotech in chemokine deal

May 1, 2001 7:00 AM UTC

AnorMed (TSE:AOM) purchased a database of compounds with activity against chemokine receptors from British Biotech (LSE:BBG; BBIOY) for C$450,000 (US$291,645). AOM said the deal relates to its existin...